On October 27 the US Food and Drug Administration Advisory Panel on Vaccines recommended the agency allow Pfizer to amend its Emergency Use Authorization for its COVID vaccine to include children 5 through 11 years old. Two days later the FDA officially approved the rollout. Major media are treating this as a positive development to […]
Source